|Salary:||£27,025 to £39,609 per annum|
|Placed On:||22nd February 2019|
|Closes:||25th March 2019|
Salary: £27,025 to £39,609 per annum, depending on skills and experience (minimum £30395 with relevant PhD). Salary progression beyond this scale is subject to performance
An enthusiastic research scientist with expertise in polymer chemistry and cancer cell biology studies of polymer therapeutics is sought for a position within the EPSRC Healthcare Technologies priority. The aim of the EPSRC Programme Grant is to develop a new generation of biomedical materials with applications in antimicrobial resistance, cancer, stem cell science and immunology. Within the programme, a theme led by Professor Cameron Alexander will investigate polymers for targeting Triple Negative Breast Cancer (TNBC). This post will contribute to the design, synthesis, and biological evaluation of novel polymers and drug delivery systems, which will act as both carriers for drugs, but also platform release materials for other applications within the grant.
The work will involve direct interactions with the partner research groups of Professors Anna Grabowska (Cancer Biology, University of Nottingham) and Steve Howdle (School of Chemistry, University of Nottingham) and with associated PhD students selected for the project. In addition, you will cooperate and collaborate with the wider grant team led by Professor Morgan Alexander, with possibilities for unprecedented interdisciplinary science spanning chemistry, biology, pharmacy and materials. You will be based in the Boots Science Building and Queens Medical Centre at Nottingham and will have the opportunity to work for extended periods in partnering laboratories for the grant as a whole, which include those of Professors Daniel Anderson at MIT, Maria Vicent in CIPF Valencia and Kristofer Thurecht in the University of Queensland, Australia.
You need to demonstrate experience in polymer synthesis, 2D and 3D breast cancer cell culture techniques as applied to the study of drug delivery systems and a strong interest in pharmaceutical science. A track record of triple negative breast cancer cell receptor analysis, targeting ligand bioconjugation, and study of intracellular toxicity mechanisms is desirable. You should have a PhD in chemistry, pharmacy, biochemistry or related disciplines, or a PhD thesis submitted, and have published work in the synthesis and biological evaluation of drug delivery materials.
This full time post is available on a fixed term contract for 12 months.
We pride ourselves on the collegial and supportive culture created by our staff. We are dedicated to creating an environment which enables both our staff to thrive and achieve their potential. Our commitment to Equality and Diversity has been recognised in the awarding of an Athena SWAN Bronze Award.
Informal enquiries may be addressed to Professor Cameron Alexander (Email: firstname.lastname@example.org; tel: 0115 8467678). Please note that applications sent directly to this email address will not be accepted.
Our University has always been a supportive, inclusive, caring and positive community. We warmly welcome those of different cultures, ethnicities and beliefs – indeed this very diversity is vital to our success, it is fundamental to our values and enriches life on campus. We welcome applications from UK, Europe and from across the globe. For more information on the support we offer our international colleagues, visit; https://www.nottingham.ac.uk/jobs/applyingfromoverseas/index2.aspx
Type / Role: